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Shenglan Tang1,2Abstract
China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR).
Over the past decade, a large number of TB control projects have been funded by the government of China and
international organizations, and epidemic in China has been effectively controlled. However TB control in China
still faced many challenges. Strategies to address these challenges may include integrating the national TB control
program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in
national TB control program, and reforming payment methods for TB care as part of health system reform in China.
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Worldwide tuberculosis (TB) remains a leading cause of
death. It was estimated 9.0 million people developed TB
and 1.5 million died from the disease, 360,000 of whom
were HIV-positive in 2013 [1]. Globally, the proportion
of new cases with multidrug-resistant TB (MDR-TB)
was 3.5% in 2013 and has not changed compared with
recent years [2]. China is the second largest TB epi-
demic with the most number of people infected with
multi-drug resistant (MDR) [1-3]. About 5.7% of newly
diagnosed TB cases, and 25.6% of previously treated TB
cases in China are multi-drug resistant [3]. Dr Li and
his colleagues reported that those being single, without
health insurance coverage, with higher life pressure, and
from low income group are high risk factors associated
with MDRTB [4]. A systematic review published recently
claimed that delay in being treated increases the risk of
spreading TB, and contributes to the development of
MDR-TB. Patients who delayed going to see a doctor were
more likely to live in rural areas, to be less educated or fe-
male [5]. Poverty, lack of health insurance, rising costs ofCorrespondence: shenglan.tang@duke.edu
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unless otherwise stated.excess payments or treatments not covered by the insur-
ance, as well as a poor understanding of TB were cited by
patients in contributing to their delay in seeing a doctor.
There is also a stigma associated with TB as reported
widely.Main text
Over the past decade, a large number of TB control pro-
jects have been funded by the government of China, the
World Bank, Department for International Development/
UK, and the Global Fund to Fight HIV/AIDS, TB and
Malaria, with a significant amount of financial resources
invested. As a consequence of these projects, TB epidemic
in China has been effectively controlled [6]. The National
TB Epidemiological Survey conducted in 2010 shows that
significant progress has been made to control TB, includ-
ing a remarkable reduction in smear- and culture-positive
TB prevalence rates and fewer TB patients are failing to
complete the treatment because of financial difficulty [6].
However, the prevalence rate of MDR-TB has changed
very little over the past decade. The active TB prevalence
rate in rural areas, particularly in the western part of rural
China, has actually increased. Among 1,301 active TB
patients detected in the survey, the proportion of the pa-
tients diagnosed prior to the survey rose from 69% in
2000 to 90% in 2010 [6]. Such a result may be due in part
to more TB patients without any reported symptoms. Or
this may imply that the TB case detection in China has
not improved, despite large investments in TB control byan Open Access article distributed under the terms of the Creative Commons
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nity. Of 740 newly-diagnosed TB patients with at least
one reported symptom in the 2010, 53% of them had
never sought any professional care, an increase from
42% in 2000 [6]. At the same time, health insurance
coverage rose from 35% in 2000, to 95% in 2010 [6].
This could indicate that the health insurance schemes,
especially operated in rural China, have not provided
sufficient financial protections to those in needs, as
often the health insurance policies do not cover out-
patient services. Among the newly- diagnosed TB pa-
tients, the average health care expenditure per patient
was 1,708 Chinese yuan, of which 84% of the expenses
were paid out of pocket, although a vast majority of
them are covered by the “new rural cooperative medical
scheme (NRCMS)” [7]. Among those 346 patients with
TB-related symptoms, only 124 patients (36%) were di-
agnosed as TB cases before the 2010 survey [6]. The TB
case detection rate among the same patient group de-
clined from 61% in 2000 to 36% in 2010, a seriously
alarming finding [6]. This illustrates that the quality of
TB care has not improved, and may have worsened in
some health facilities.
What should be done? These problems clearly indi-
cate that concerted actions are badly needed in order to
tackle the challenge of TB/MDR-TB facing China. The
Chinese health policy makers and TB control program
managers should develop new strategies that can be
more cost-effective and implemented to achieve the goal
of eliminating TB by 2050, as advocated by WHO in re-
cent years [8]. I believe following action would help the
national TB control program to make a greater progress
in fighting against TB/MDR-TB.
It is critically important to integrate the national TB
control program into the health system development, es-
pecially health insurance schemes. However, it is essen-
tial, but not sufficient, as the health insurance policies
often require a co-payment [9], which may be a financial
barrier for TB patients to get their illnesses diagnosed
timely, and for diagnosed TB patients to complete their
due treatments. TB is an infectious disease of poverty,
often affecting the poor and vulnerable, as reported by
many studies. A modest deductible or co-insurance pay-
ment could be a financial burden placed on their house-
holds. Hence, the national TB control program should
also work with the Ministry of Civil Affairs that is re-
sponsible for medical financing assistance for the poor
to ensure that TB patients, particularly MDR-TB pa-
tients, can be diagnosed timely and then treated success-
fully, regardless of their ability to pay for health care. It
is good to see that with the support from the Gates
Foundation, China CDC has tried to develop such con-
certed actions to reduce financial burden of TB/MDR-
TB care placed on the patients.The national TB control program, as part of China
CDC system, should also closely work with the Chinese
hospital sector to strengthen TB case management, par-
ticularly in the rural areas. There should be clear clinical
guidelines for treatment and effective case management
put in place. It is also crucial to develop monitoring and
evaluation systems to assess the performance of these
so-called TB designated hospitals.
Paying for TB care should also be seen as part of the
health system reform in China [10]. This can be accom-
plished by using alternative provider payment methods
to fee-for-services, in order to remove perverse financial
incentives and reduce moral hazards of the Chinese
hospitals, the majority of which have been maximizing
their profits from service provision and drug sale over
the past 2–3 decades. Without effective cost contain-
ment measures, more financial resources for TB control
and care might be wasted, let alone being able to pro-
duce the health gains that the government is expecting.
Conclusion
Strategies to address current challenges in China need
to integrate the national TB control program into health
insurance schemes, strengthening TB case management
through involving the Chinese hospital in national TB
control program, and reforming payment methods for
TB care as part of health system reform in China.
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